Study Inflammation During a 100 Miles

Per Effort Study of Inflammation During a 100 Miles

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03256006

Acronym

TRAIL PHYSIO

Enrollment

Registered

2017-08-21

Start date

2018-10-18

Completion date

2018-10-29

Last updated

2018-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Response

Keywords

sport exercise, ultra endurance

Brief summary

To study per and post effort variations of inflammatory biological markers during a 100 miles

Interventions

OTHERBlood sample

Blood sample to study per and post effort evolution markers of systemic inflammation

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* adults (age\>18years) * completion of an ultra endurance race (50 miles) during the 2 years before

Exclusion criteria

* female * age\<18years

Design outcomes

Primary

Measure	Time frame	Description
Variation per and post effort of interleukin 1 plasma level	Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race	Plasma level of per and post effort of interleukin 1 will be measured
Variation per and post effort of interleukin 6 plasma level	Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race	Plasma level of per and post effort of interleukin 6 will be measured
Variation of per and post effort of protein C reactive	Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race	Plasma level of per and post effort of protein C reactive will be measured
Variation per and post effort of interleukin Tumor Necrosis Factor alpha	Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race	Plasma level of per and post effort of tumor necrosis alpha will be measured
Variation per and post effort of interleukin 4 plasma level	Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race	Plasma level of per and post effort of interleukin 4 will be measured
Variation per and post effort of interleukin 10 plasma level	Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race	Plasma level of per and post effort of interleukin 10 will be measured
Variation per and post effort of interleukin 13 plasma level	Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race	Plasma level of per and post effort of interleukin 13 will be measured
Variation per and post effort of interleukin tumor growth factor beta plasma level	Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race	Plasma level of per and post effort of tumor growth factor beta
Variation per and post effort of lipids plasma level	Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race	Plasma level of per and post effort of lipids
Variation per and post effort of lipoproteins plasma level	Change measures : departure, 25, 49, 72, 100, 126, 144, 164 kilometers (arrival) then at day 1, day 2 and day 7 after the completion of the race	Plasma level of per and post effort of lipoproteins

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026